Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1355455-26-3

1355455-26-3

Post Buying Request

1355455-26-3 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1355455-26-3 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1355455-26-3 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,5,5,4,5 and 5 respectively; the second part has 2 digits, 2 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 1355455-26:
(9*1)+(8*3)+(7*5)+(6*5)+(5*4)+(4*5)+(3*5)+(2*2)+(1*6)=163
163 % 10 = 3
So 1355455-26-3 is a valid CAS Registry Number.

1355455-26-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 16, 2017

Revision Date: Aug 16, 2017

1.Identification

1.1 GHS Product identifier

Product name benzyl 3-{[(methylsulfonyl)oxy]methyl}pyrrolidine-1-carboxylate

1.2 Other means of identification

Product number -
Other names Benzyl 3-(((methylsulfonyl)oxy)methyl)pyrrolidine-1-carboxylate

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:1355455-26-3 SDS

1355455-26-3Relevant articles and documents

NEW MACROCYCLIC LRRK2 KINASE INHIBITORS

-

Page/Page column 224-225, (2021/11/13)

Compounds of formula (I): wherein R, X1, X2, X3, Z1, Z2, Z3, A and Ra are as defined in the description. Medicaments.

Disubstituted pyrimidines as Lck inhibitors

Hunt, Julianne A.,Beresis, Richard T.,Goulet, Joung L.,Holmes, Mark A.,Hong, Xinfang J.,Kovacs, Ernest,Mills, Sander G.,Ruzek, Rowena D.,Wong, Frederick,Hermes, Jeffrey D.,Park, Young-Whan,Salowe, Scott P.,Sonatore, Lisa M.,Wu, Lin,Woods, Andrea,Zaller, Dennis M.,Sinclair, Peter J.

supporting information; experimental part, p. 5440 - 5443 (2010/04/26)

We have developed a family of 4-benzimidazolyl-N-piperazinethyl-pyrimidin-2-amines that are subnanomolar inhibitors of Lck. A subset of these Lck inhibitors, with heterocyclic substituents at the benzimidazole C5, are also low-nanomolar inhibitors of cell

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1355455-26-3